Charlottesville, VA, 3 November, 2008 Biovista is glad to announce its sponsoring of the Drug Repurposing Strategies conference to be held in Philadelphia, December 10-11, 2008. Focusing on the identification, licensing and repositioning of compounds and existing or abandoned drugs, the conference will explore strategies and approaches to bolster pipelines, reduce risk and control the … Read More
Year: 2008
Cempra Pharmaceuticals and Biovista Inc. enter agreement for macrolide CT design support
CHAPEL HILL, N.C. and CHARLOTTESVILLE, Va.–(Business Wire)–Cempra Pharmaceuticals, Inc., and Biovista, Inc., announced today that they have entered into a research agreement to systematically identify and profile adverse event associations for members of the macrolide drug class. The data generated will be used to better understand the unique benefit/risk characteristics of this important group of … Read More
Nano2life 2008: Knowledge Discovery using literature mining
Knowledge Discovery using literature mining Heraklion, Crete Dr. Andreas Persidis, Biovista Date: Friday, 27 June 2008 Section: Nano2Life Scientific Meetings
Biovista initiates its Macular Degeneration and CNS drug repositioning programs.
Charlottesville, VA and Athens, Greece. Biovista began work today on two internal programs aimed to reposition marketed drugs or drugs in Phase II/III in Macular Degeneration and CNS. Biovista has already identified a number of candidates with the requisite biological plausibility that are also unencumbered by prior patent filings or prior art. The Company is … Read More